City

Shanghai (1)

Condition

Erosive Esophagitis (EE) (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (1)

Collaborator

Intervention

esomeprazole 40mg (1)

lxi-15028 50mg (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

erosive esophagitis (ee)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Erosive Esophagitis (EE) Trial in Shanghai (LXI-15028 50mg, Esomeprazole 40mg)

Completed

Erosive Esophagitis (EE)

LXI-15028 50mg
Esomeprazole 40mg

Shanghai, Shanghai, China

Shanghai First People's Hospital

Apr 14, 2020